» Articles » PMID: 28300760

The Essential Role of Pin1 Via NF-κB Signaling in Vascular Inflammation and Atherosclerosis in ApoE Mice

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Mar 17
PMID 28300760
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis, as a chronic inflammatory disease, is the major underlying cause of death worldwide. However, the mechanisms that underlie the inflammatory process are not completely understood. Prolyl-isomerase-1 (Pin1), as a unique peptidyl-prolyl isomerase, plays an important role in inflammation and endothelial dysfunction. Herein, we investigate whether Pin1 regulates vascular inflammation and atherosclerosis, and clarify its mechanisms in these processes. ApoE mice were randomly given either juglone (0.3, 1 mg/kg, two times per week) or vehicle i.p. for 4 weeks. Compared with ApoE mice, treatment by juglone resulted not only in markedly attenuated macrophage infiltration and atherosclerotic lesion area in a lipid-independent manner, but also in decreased expression of Pin1, vascular cell adhesion molecule-1 (VCAM-1), monocyte chemoattractant protein-1 (MCP-1), and NF-κB activity in aorta. Then, EA.hy926 cells were pretreated with juglone (6 μmol/L), Pin1 siRNA, NF-κB inhibitor, or vehicle prior to exposure to ox-LDL (50 μg/mL). It was observed that treatment with juglone or Pin1 siRNA suppressed expression of VCAM-1 in oxLDL-incubated EA.hy926 cells and decreased THP-1 cell adhesion to oxLDL-stimulated endothelial cells through the NF-κB signal pathway. Our findings indicate that Pin1 plays a vital role on the development of vascular inflammation and atherosclerosis.

Citing Articles

Exploring the mechanism of atherosclerosis and the intervention of traditional Chinese medicine combined with mesenchymal stem cells based on inflammatory targets.

Sun S, Liu F, Fan F, Chen N, Pan X, Wei Z Heliyon. 2023; 9(11):e22005.

PMID: 38045166 PMC: 10692769. DOI: 10.1016/j.heliyon.2023.e22005.


GSDME in Endothelial Cells: Inducing Vascular Inflammation and Atherosclerosis via Mitochondrial Damage and STING Pathway Activation.

Xie S, Su E, Song X, Xue J, Yu P, Zhang B Biomedicines. 2023; 11(9).

PMID: 37761020 PMC: 10526370. DOI: 10.3390/biomedicines11092579.


Inhibition of GSDMD activation by Z-LLSD-FMK or Z-YVAD-FMK reduces vascular inflammation and atherosclerotic lesion development in ApoE mice.

Zhang B, Yu P, Su E, Zhang C, Xie S, Yang X Front Pharmacol. 2023; 14:1184588.

PMID: 37593179 PMC: 10427923. DOI: 10.3389/fphar.2023.1184588.


Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase.

Chen X, Igumenova T Adv Biol Regul. 2022; 87:100938.

PMID: 36496344 PMC: 9992314. DOI: 10.1016/j.jbior.2022.100938.


Pin1 as Molecular Switch in Vascular Endothelium: Notes on Its Putative Role in Age-Associated Vascular Diseases.

Fagiani F, Vlachou M, Di Marino D, Canobbio I, Romagnoli A, Racchi M Cells. 2021; 10(12).

PMID: 34943794 PMC: 8699654. DOI: 10.3390/cells10123287.


References
1.
Barroso M, Kao D, Blom H, Tavares de Almeida I, Castro R, Loscalzo J . S-adenosylhomocysteine induces inflammation through NFkB: A possible role for EZH2 in endothelial cell activation. Biochim Biophys Acta. 2015; 1862(1):82-92. PMC: 4674364. DOI: 10.1016/j.bbadis.2015.10.019. View

2.
Lu K, Finn G, Lee T, Nicholson L . Prolyl cis-trans isomerization as a molecular timer. Nat Chem Biol. 2007; 3(10):619-29. DOI: 10.1038/nchembio.2007.35. View

3.
Harja E, Bu D, Hudson B, Chang J, Shen X, Hallam K . Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest. 2007; 118(1):183-94. PMC: 2129235. DOI: 10.1172/JCI32703. View

4.
Lu K, Zhou X . The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol. 2007; 8(11):904-16. DOI: 10.1038/nrm2261. View

5.
Liu M, Yu Y, Jiang H, Zhang L, Zhang P, Yu P . Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis. Acta Pharmacol Sin. 2013; 34(6):830-6. PMC: 4002903. DOI: 10.1038/aps.2013.8. View